DiabetologyNews.net

Diabetology Xagena

Search results for "Sotagliflozin"

The pivotal inTandem1 phase 3 clinical trial of Sotagliflozin met its primary endpoint, showing a statistically significant reduction in A1C at 24 weeks in patients with type 1 diabetes on a backgroun ...